Approval of Devyser’s RHD product in Canada

STOCKHOLM, May 11, 2023 /PRNewswire/ — Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted regulatory approval in Canada. Devyser already has a contract with Canada’s Héma-Québec to deliver RHD tests. The product approval by Health Canada…

Leave a Reply

Your email address will not be published. Required fields are marked *